rs201088712
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP5BP4
The NM_018451.5(CENPJ):āc.1263G>Cā(p.Gln421His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000156 in 1,614,168 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_018451.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CENPJ | NM_018451.5 | c.1263G>C | p.Gln421His | missense_variant | 7/17 | ENST00000381884.9 | NP_060921.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CENPJ | ENST00000381884.9 | c.1263G>C | p.Gln421His | missense_variant | 7/17 | 1 | NM_018451.5 | ENSP00000371308.4 | ||
CENPJ | ENST00000616936.4 | n.1263G>C | non_coding_transcript_exon_variant | 7/16 | 1 | ENSP00000477511.1 | ||||
CENPJ | ENST00000545981.6 | n.1263G>C | non_coding_transcript_exon_variant | 7/18 | 2 | ENSP00000441090.2 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152200Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000163 AC: 41AN: 251358Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135848
GnomAD4 exome AF: 0.000151 AC: 221AN: 1461850Hom.: 0 Cov.: 34 AF XY: 0.000149 AC XY: 108AN XY: 727226
GnomAD4 genome AF: 0.000204 AC: 31AN: 152318Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74490
ClinVar
Submissions by phenotype
Seckel syndrome 4 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 26, 2014 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.1263G>C (p.Q421H) alteration is located in exon 7 (coding exon 6) of the CENPJ gene. This alteration results from a G to C substitution at nucleotide position 1263, causing the glutamine (Q) at amino acid position 421 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 07, 2022 | This sequence change replaces glutamine, which is neutral and polar, with histidine, which is basic and polar, at codon 421 of the CENPJ protein (p.Gln421His). This variant is present in population databases (rs201088712, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with CENPJ-related conditions. ClinVar contains an entry for this variant (Variation ID: 210654). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at